Publikationen, an denen er mitarbeitet María Blanco Prieto (74)

2024

  1. Rna-loaded nanoparticles for the treatment of hematological cancers

    Advanced Drug Delivery Reviews, Vol. 214

2023

  1. Alginate and collagen-based hydrogel: a novel cardiactherapeutic platform for extracellular vesicle delivery

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  2. Lipid nanoparticles for siRNA delivery in cancer treatment

    Journal of Controlled Release, Vol. 361, pp. 130-146

  3. Supramolecular nanoreinforced hydrogel provides 3Dinteractions to mesenchymal stem cells and boosts theirpotential in Parkinson’s disease

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2022

  1. Development of an injectable alginate-collagen hydrogel for cardiac delivery of extracellular vesicles

    International Journal of Pharmaceutics, Vol. 629

  2. Encapsulation of MSCs and GDNF in an Injectable Nanoreinforced Supramolecular Hydrogel for Brain Tissue Engineering

    Biomacromolecules, Vol. 23, Núm. 11, pp. 4629-4644

  3. Hydrogels for brain repair: application to Parkinson’s disease

    Expert Opinion on Drug Delivery, Vol. 19, Núm. 11, pp. 1521-1537

  4. Isolation methods of large and small extracellular vesicles derived from cardiovascular progenitors: A comparative study

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 170, pp. 187-196

  5. Neuroinflamación en la enfermedad de Parkinson

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 3, Núm. 1, pp. 14-24

2021

  1. Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction

    Acta Biomaterialia, Vol. 126, pp. 394-407

  2. Extracellular vesicle-based therapeutics for heart repair

    Nanomaterials, Vol. 11, Núm. 3, pp. 1-30

  3. Optimization of a GDNF production method based on Semliki Forest virus vector

    European Journal of Pharmaceutical Sciences, Vol. 159

2020

  1. Combinatorial nanomedicine made of squalenoyl-gemcitabine and edelfosine for the treatment of osteosarcoma

    Cancers, Vol. 12, Núm. 7, pp. 1-13

2019

  1. Long-term engraftment of human cardiomyocytes combined with biodegradable microparticles induces heart repair

    Journal of Pharmacology and Experimental Therapeutics, Vol. 370, Núm. 3, pp. 761-771

  2. NRG1 PLGA MP locally induce macrophage polarisation toward a regenerative phenotype in the heart after acute myocardial infarction

    Journal of Drug Targeting, Vol. 27, Núm. 5-6, pp. 573-581

  3. Nanobiotechnology in parkinson’s disease

    Nanobiotechnology in Neurodegenerative Diseases (Springer International Publishing), pp. 177-208

2018

  1. Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma

    Cancer Letters, Vol. 430, pp. 193-200

2017

  1. Bioresorbable polymers for next-generation cardiac scaffolds

    Bioresorbable Polymers for Biomedical Applications: From Fundamentals to Translational Medicine (Elsevier), pp. 445-467

  2. Cardiac drug delivery

    Drug Delivery: An Integrated Clinical and Engineering Approach (CRC Press), pp. 439-480

  3. Cytokine-loaded PLGA and PEG-PLGA microparticles showed similar heart regeneration in a rat myocardial infarction model

    International Journal of Pharmaceutics, Vol. 523, Núm. 2, pp. 531-533